Beta

Beta. We're still building this. Tell us

LongevityImmuneInjectableExperimentalBioregulator

Vilon

A two-amino-acid Russian immune bioregulator, run in short daily courses. Old, small studies from one institute; most feel nothing.

UnderstandWhat it isApplyHow to use it

What it is

Vilon is the smallest peptide on this site, just lysine and glutamic acid joined together, and it is the thymus-and-immune member of the Khavinson bioregulator family. People run it in 10 to 20 day courses a few times a year hoping to prop up an aging immune system. The usual dose is 250 mcg to 1 mg a day, and the evidence is decades-old Russian cell, animal and small elderly-patient work that nobody outside that network has repeated.

Vilon's audience is the longevity rotation crowd: people in their 50s and beyond cycling Epitalon for the pineal and sleep, Pinealon for the brain, and Vilon for the thymus, the gland behind the breastbone that trains immune cells and shrinks with age. A smaller group is people who catch every cold going around and have read the Russian claims about immune 'normalization'. Almost nobody runs Vilon alone or as their first peptide.

What you will notice: nothing, most likely. There is no feeling that goes with a dipeptide at a few hundred mcg, and the claimed effect, immune markers moving toward a younger pattern, is invisible without a lab panel. People who say they got fewer colds the winter they ran it are reporting a season, not a result. The animal data on tumor rates and lifespan is the thing most likely to be misread; it is a reason the institute kept studying it, not a reason for you to run it as cancer prevention.

Dosing is simple once the scale is right. Courses run 250 mcg, 500 mcg or 1 mg subQ once a day for 10 to 20 days (up to 30), then several months off before the next course, and 500 mcg is the usual middle. The gap is not because it wears off: the effect is meant to carry on for months after a course, so running it straight through gains nothing, and the exact spacing is up to you. You will see 5 or 10 mcg quoted; that is a unit slip, a fraction of one syringe line that nobody can draw, and the rest of the bioregulator family is dosed in the hundreds of mcg or more. Mix a 10 mg vial with 1 ml of bacteriostatic water and it is 10 mg/ml, so 250 mcg is 2.5 units, 500 mcg is 5 units and 1 mg is 10 units. A 20-day course at 500 mcg uses one vial; at 1 mg it takes two.

Evidence sits at animal 2, human 1. The paper trail is real but old, small and Russian-language, almost entirely from the St. Petersburg Institute of Bioregulation and Gerontology: thymus cell cultures, rodent immune and lifespan models, and small studies in elderly people reporting shifts in lymphocyte and cytokine markers. Nothing has been replicated to modern standards elsewhere, so the honest read is 'plausible, cheap to test on yourself, impossible to verify without labs'.

Not worth it if you want an immune peptide with actual human data: Thymosin Alpha-1 is approved in several countries for hepatitis and as an immune adjuvant, and it is on this site. Not worth it if you have an autoimmune disease, a transplant or a cancer history, where 'modulating' immunity is the opposite of a casual experiment. If you just want the Khavinson rotation, Epitalon has more human footing than Vilon and is where to start.

Best known for
Immune and thymus 'bioregulation' in longevity rotations
How it's taken
SubQ shot, 250 mcg to 1 mg once a day; 2.5 to 10 units from a 10 mg vial in 1 ml
How fast
Nothing you can feel; any effect is only visible on an immune lab panel
How long a cycle
10 to 20 days, up to 30. Several months before the next course
Pairs with
Epitalon in a rotation. For proven immune support, Thymosin Alpha-1 instead

What people use it for

Immune aging and the thymus

Early days

In thymus cell cultures and aged rodents, Vilon shifted lymphocyte activity and cytokine signaling toward a younger pattern, including more IL-2 and less inflammatory signaling. Small studies in elderly Russian patients reported similar marker changes. One institute, decades ago, no modern replication, and no infection or illness outcome measured.

Fewer infections

Early days

This is what people hope for and nothing has tested it. The Russian elderly studies measured immune markers, not how many colds or pneumonias people got. If you run a course over winter and stay healthy, you cannot credit Vilon, and the same goes for the reverse.

Lifespan and tumors in animals

Early days

Mouse and rat work from the Khavinson group reported longer lifespan and lower tumor rates in some models. This is the most-quoted and most-misread Vilon finding. Rodent carcinogenesis models do not translate into cancer prevention in people, and using it that way is a mistake, especially if cancer is in your history.

Gene expression

Early days

The group reports Vilon affecting chromatin and gene-expression patterns in immune cells, which is why it gets called an 'epigenetic bioregulator'. Interesting as mechanism, unmeasurable in yourself, and not evidence of a benefit.

How people use it

RouteSubQ
How oftenOnce a day
How long10 to 20 days, up to 30
Ready to use it?Dosing and reconstitution guide
+ Track this peptide

Safety, in brief

Things people sometimes notice

  • A small red spot at the injection site
  • Nothing systemic at 250 mcg to 1 mg; most people feel no difference at all

The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.

Sources

The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.

  1. Effect of peptide Lys-Glu on interleukin-2 gene expression in lymphocytesKhavinson et al., Bull Exp Biol Med 2000 · Study
  2. Effect of vilon on the immunity status and coagulation hemostasis in patients of different age with diabetes mellitusKuznik et al., Adv Gerontol 2007 · Trial
  3. A synthetic dipeptide vilon (L-Lys-L-Glu) inhibits growth of spontaneous tumors and increases life span of miceKhavinson et al., Dokl Biol Sci 2000 · Study
  4. Effects of short peptides on lymphocyte chromatin in senile subjectsKhavinson et al., Bull Exp Biol Med 2004 · Study
This is education, not medical advice. Peptides affect everyone differently. Please talk with a doctor before starting anything, especially if you take other medicines or have a health condition.
© 2026 PeptideHelp. This platform is for educational purposes only.
Vilon: what it does, research & side effects · PeptideHelp